Oak Associates LTD Novartis Ag Transaction History

Oak Associates LTD

  • $1.64 Billion
  • Q3 2025

A detailed history of Oak Associates LTD transactions in Novartis Ag stock. As of the latest transaction made, Oak Associates LTD holds 155,859 shares of NVS stock, worth $20.5 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
155,859
Previous 157,880 1.28%
Holding current value
$20.5 Million
Previous $19.1 Million 4.62%
% of portfolio
1.22%
Previous 1.27%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$113.5 - $129.73 $229,383 - $262,184
-2,021 Reduced 1.28%
155,859 $20 Million
Q2 2025

Aug 12, 2025
BUY
$101.96 - $121.01 $558,842 - $663,255
5,481 Added 3.6%
157,880 $19.1 Million
Q1 2025

May 14, 2025
BUY
$97.14 - $115.57 $35,456 - $42,183
365 Added 0.24%
152,399 $17 Million
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $55,930 - $63,709
527 Added 0.35%
152,034 $17.5 Million
Q2 2024

Aug 08, 2024
SELL
$92.57 - $107.37 $60,263 - $69,897
-651 Reduced 0.43%
151,507 $16.1 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $64,307 - $73,217
-675 Reduced 0.44%
152,158 $14.7 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $442,342 - $486,782
4,794 Added 3.24%
152,833 $15.4 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $218,352 - $242,324
2,305 Added 1.58%
148,039 $15.1 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $2.87 Million - $3.25 Million
-31,025 Reduced 17.55%
145,734 $14.7 Million
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $81,390 - $94,387
1,017 Added 0.58%
176,759 $16.3 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $705,637 - $864,136
-9,340 Reduced 5.05%
175,742 $15.9 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $1.65 Million - $1.93 Million
-22,092 Reduced 10.66%
185,082 $14.1 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $148,639 - $173,062
-1,846 Reduced 0.88%
207,174 $17.5 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $356,809 - $403,621
-4,454 Reduced 2.09%
209,020 $18.3 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $127,838 - $141,360
-1,604 Reduced 0.75%
213,474 $18.7 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $106,550 - $117,687
-1,250 Reduced 0.58%
215,078 $19.6 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $1.93 Million - $2.27 Million
-23,099 Reduced 9.65%
216,328 $18.5 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $305,971 - $338,975
-3,725 Reduced 1.53%
239,427 $20.8 Million
Q2 2020

Aug 11, 2020
SELL
$80.93 - $91.1 $254,201 - $286,145
-3,141 Reduced 1.28%
243,152 $21.2 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $179,572 - $251,584
-2,541 Reduced 1.02%
246,293 $20.3 Million
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $440,306 - $497,831
-5,220 Reduced 2.05%
248,834 $23.6 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $130,362 - $143,652
-1,524 Reduced 0.6%
254,054 $22.1 Million
Q2 2019

Aug 09, 2019
BUY
$75.4 - $92.8 $3.43 Million - $4.22 Million
45,485 Added 21.65%
255,578 $23.3 Million
Q1 2019

May 09, 2019
BUY
$75.32 - $86.15 $2.91 Million - $3.33 Million
38,684 Added 22.57%
210,093 $20.2 Million
Q4 2018

Feb 07, 2019
SELL
$73.66 - $82.02 $132,735 - $147,800
-1,802 Reduced 1.04%
171,409 $14.7 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $1.16 Million - $1.35 Million
17,396 Added 11.16%
173,211 $14.9 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $9.15 Million - $10.3 Million
140,915 Added 945.74%
155,815 $11.8 Million
Q4 2017

Feb 08, 2018
BUY
$72.33 - $77.64 $1.08 Million - $1.16 Million
14,900
14,900 $1.25 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email